LEADER 01625nam  2200409Ia 450 
001 9910698826903321
005 20090528132734.0
035   $a(CKB)5470000002397599
035   $a(OCoLC)355314986
035   $a(EXLCZ)995470000002397599
100   $a20090528d2001      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $erecommendations for assessment of donor suitability and blood and blood product safety in cases of possible exposure to anthrax
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,$d[2001]
215   $ai, 7 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on May 28, 2009).
300   $a"Final guidance".
300   $a"October 2001".
300   $aIncludes bibliographical references (p. 6).
517   $aGuidance for industry 
606   $aBlood donors$xGovernment policy$zUnited States
606   $aBlood products$xEvaluation$xGovernment policy$zUnited States
606   $aAnthrax$xPrevention$xGovernment policy$zUnited States
615  0$aBlood donors$xGovernment policy
615  0$aBlood products$xEvaluation$xGovernment policy
615  0$aAnthrax$xPrevention$xGovernment policy
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698826903321
996   $aGuidance for industry$93434577
997   $aUNINA